Pediatric Formulation (Mini-tablet)

Patient-Centric Innovation

Pediatric Formulation: 2 mm Mini-Tablet Technology

Precision dosing for populations from neonates to adolescents. Driven by patient needs and evolving regulatory requirements.

Advantage

Why Choose Mini-Tablet?

Patient Compliance

Optimal Size: Better acceptability for small children.
Accurate Dosing: Eliminates measuring errors.
Sensory Appeal: Engineered for taste & mouthfeel.

Clinical Flexibility

Single Formulation: Titrate across age groups.
Functional Coating: Taste-masking or Controlled Release.
Adaptable Delivery: Sprinkle on food options.

Commercial Advantages

Superior Stability: Longer shelf-life than liquids.
Cost Efficiency: Reduced shipping & storage costs.
Simplified Supply Chain: Minimized SKUs.

Manufacturing

Specialized Unit Operations

Precision Compression

2 mm diameter scale
Weight range 7-9 mg
Content uniformity control

Advanced Film Coating

Precision micro-scale coating
Taste-masking application
Modified release profiles

Specialized Packaging

Sprinkle capsules
Accurate stickpack solutions
Caregiver-friendly designs

Crystal Pharmatech Expertise

Our Expertise in Mini-Tablet Technology

The Crystal Pharmatech formulation team possesses deep expertise in specialized unit operations required for micro-scale manufacturing.

Complete "end-to-end" process train
Scientifically sound and patient-ready formulations
From prototype development to commercialization

Precision Pediatric Manufacturing

Achieve Your Success with Our Expertise

Have a question or need support with your project? Please complete the form, and our team will get back to you shortly.  

Our capabilities span three specialized platforms:

Small Molecule
Crystal Bio Solutions
Crystal NAX

By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your inquiry. The information you submit will be governed by our Privacy Policy.

Related Resources

Crystal Pharmatech Formulation Forum

Drug Delivery and Patient Centric Approaches to Drug Development

11 Mar 2025



Crystal Pharmatech Formulation Forum

Patient-Centered Controlled and Modified Release Drug Delivery: Formulation & Process Development

21 May 2025



Small Molecule

First-Time-Right 3-STEP Approach Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Analytical Research and Quality Control Formulation Development Clinical and Commercial GMP Manufacturing Clinical Supply

Crystal Bio Solutions

Biologics Characterization and CMC Analytics Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)

Crystal NAX

DNA Synthesis RNA Synthesis LNP Formulation Services Analytical & Characterization Services Early-Phase Manufacturing Catalogue Products

Platforms

Solid Form Screening Solid Form Developability Evaluation Absolute Structure Determination Crystallization Process Development Conventional Oral Solid Dosage Forms Bioavailability Enhancement for Insoluble Compounds & PROTAC & Oral Peptides Mini-tablet

Quick Links

Highlights News Events Knowledge Hub Webinar Series

 bd_global@crystalpharmatech.com  (925) 558-5040



U.S
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566

Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1

China
No. 288, Jiangyun Road, Suzhou Industrial Park, Suzhou, China 215123

Floor 1, Bldg. 3, 68 Chunpu Road, Suzhou Industrial Park, Suzhou, China 215123

Subscribe to be the first to get the updates!

Sitemap